ARCHIVES

Supreme Court Decision Means FTC Scrutiny As Costly Oncology Drugs Go Off-Patent

This article is from The Cancer Letter archive.

Vol. 39 No. 25 | June 21, 2013

Download PDF Visit The Full Archive

Related Articles

Bush Names Leffall Cancer Panel Chairman, Appoints Cyclist Armstrong To Panel

May 31, 2002

Insurance Co. Official Says Cancer Centers, Insurers Are “Allies”

June 2, 1995

Professional Societies: FASEB Urges Increase Of 15% For NIH, Double In Five Years

March 6, 1998

Trastuzumab Increases Risks Of Congestive Heart Failure

August 31, 2012

St. Jude Offers Three Fellowships

March 2, 1984

No Protective Effect From Long-Term Vitamin E or C

November 28, 2008